Xencor Inc (XNCR)
18.98
-0.09
(-0.47%)
USD |
NASDAQ |
Apr 18, 16:00
18.95
-0.03
(-0.16%)
After-Hours: 20:00
Xencor Enterprise Value: 587.65M for April 18, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| April 18, 2024 | 587.65M |
| April 17, 2024 | 593.15M |
| April 16, 2024 | 583.98M |
| April 15, 2024 | 656.72M |
| April 12, 2024 | 679.33M |
| April 11, 2024 | 681.77M |
| April 10, 2024 | 666.49M |
| April 09, 2024 | 744.73M |
| April 08, 2024 | 741.67M |
| April 05, 2024 | 728.84M |
| April 04, 2024 | 733.73M |
| April 03, 2024 | 742.89M |
| April 02, 2024 | 742.28M |
| April 01, 2024 | 767.34M |
| March 28, 2024 | 780.18M |
| March 27, 2024 | 797.90M |
| March 26, 2024 | 743.51M |
| March 25, 2024 | 766.12M |
| March 22, 2024 | 810.13M |
| March 21, 2024 | 821.74M |
| March 20, 2024 | 818.07M |
| March 19, 2024 | 818.68M |
| March 18, 2024 | 787.51M |
| March 15, 2024 | 838.85M |
| March 14, 2024 | 774.07M |
| Date | Value |
|---|---|
| March 13, 2024 | 855.36M |
| March 12, 2024 | 821.13M |
| March 11, 2024 | 841.30M |
| March 08, 2024 | 909.75M |
| March 07, 2024 | 881.64M |
| March 06, 2024 | 884.08M |
| March 05, 2024 | 824.18M |
| March 04, 2024 | 889.58M |
| March 01, 2024 | 883.47M |
| February 29, 2024 | 830.30M |
| February 28, 2024 | 820.52M |
| February 27, 2024 | 1.048B |
| February 26, 2024 | 1.009B |
| February 23, 2024 | 923.20M |
| February 22, 2024 | 918.31M |
| February 21, 2024 | 899.97M |
| February 20, 2024 | 863.91M |
| February 16, 2024 | 903.64M |
| February 15, 2024 | 729.45M |
| February 14, 2024 | 653.65M |
| February 13, 2024 | 593.87M |
| February 12, 2024 | 678.66M |
| February 09, 2024 | 612.17M |
| February 08, 2024 | 565.20M |
| February 07, 2024 | 568.25M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
511.74M
Minimum
Nov 09 2023
2.515B
Maximum
Feb 08 2021
1.356B
Average
1.350B
Median
Enterprise Value Benchmarks
| Ionis Pharmaceuticals Inc | 4.900B |
| Karyopharm Therapeutics Inc | 126.19M |
| NovaBay Pharmaceuticals Inc | 2.485M |
| Palatin Technologies Inc | 21.01M |
| iBio Inc | 16.03M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -19.10M |
| Revenue (Quarterly) | 44.69M |
| Total Expenses (Quarterly) | 79.70M |
| EPS Diluted (Quarterly) | -0.31 |
| Profit Margin (Quarterly) | -42.74% |
| Earnings Yield | -11.06% |
| Normalized Earnings Yield | -10.78 |